First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
32.53
+0.14 (0.45%)
Dec 12, 2025, 4:00 PM EST - Market closed
FTXH Holdings Information
FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are Johnson & Johnson stock at 7.40%, Merck & Co. at 7.35%, Bristol-Myers Squibb Company at 6.77%, AbbVie at 6.65%, and Pfizer at 6.50%.
Total Holdings
25
Top 10 Percentage
54.70%
Asset Class
Equity
ETF Category
Health
Assets
19.52M
PE Ratio
17.06
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | 7.40% |
| 2 | MRK | Merck & Co., Inc. | 7.35% |
| 3 | BMY | Bristol-Myers Squibb Company | 6.77% |
| 4 | ABBV | AbbVie Inc. | 6.65% |
| 5 | PFE | Pfizer Inc. | 6.50% |
| 6 | LLY | Eli Lilly and Company | 4.30% |
| 7 | CAH | Cardinal Health, Inc. | 4.16% |
| 8 | REGN | Regeneron Pharmaceuticals, Inc. | 4.01% |
| 9 | BIIB | Biogen Inc. | 4.00% |
| 10 | VRTX | Vertex Pharmaceuticals Incorporated | 3.56% |
| 11 | AMGN | Amgen Inc. | 3.44% |
| 12 | VTRS | Viatris Inc. | 3.43% |
| 13 | UTHR | United Therapeutics Corporation | 3.41% |
| 14 | GILD | Gilead Sciences, Inc. | 3.40% |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 2.42% |
| 16 | ZTS | Zoetis Inc. | 2.35% |
| 17 | ILMN | Illumina, Inc. | 2.12% |
| 18 | PTCT | PTC Therapeutics, Inc. | 1.68% |
| 19 | INCY | Incyte Corporation | 1.52% |
| 20 | CRL | Charles River Laboratories International, Inc. | 1.49% |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.37% |
| 22 | EXEL | Exelixis, Inc. | 1.29% |
| 23 | MEDP | Medpace Holdings, Inc. | 1.18% |
| 24 | ELAN | Elanco Animal Health Incorporated | 1.03% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 0.97% |
As of Dec 11, 2025